RBRimir R. Bayazitov

Rimir R. Bayazitov

*This is an algorithmically generated author record based on publicly available information.

Rimir R. Bayazitov has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Systemic inflammation in missed abortion

    by T.A. Gusarova, N.V. Nizyaeva, A.P. Aleksankin, M.в. Babadzhanova, S.M. Semyatov, R.R. Bayazitov

  • Neutrophils of peripheral blood and products of conception in non-viable pregnancy

    by T.A. Gusarova, N.V. Nizyaeva, T.V. Fokina, A.A. Akhmetshina, A.P. Aleksankin, R.R. Baiazitov, L.M. Mikhaleva

    Introduction. According to clinical guidelines, the diagnosis of non-viable pregnancy relies on ultrasound and the assessment of placental hormone levels. In early pregnancy, diagnosis requires expert evaluation. Hormone levels fluctuate, which is why it is challenging to diagnose non-viable pregnancy at early stages, which requires repeated examination in a 1–2-week time. Therefore, more sensitive biomarkers are needed to predict miscarriage and assess embryo viability. The study aimed to conduct a molecular morphological analysis of the products of conception and peripheral blood in missed abortion. Materials and methods. The study included 103 women (18–42 years) at 5–14 weeks of gestation: 45 patients had missed abortion; 20 patients, spontaneous miscarriage; and 38, elective abortion in healthy women (the comparison group). Histological examination and immunohistochemistry with antibodies to neutrophil elastase and proteinase 3 were performed. Serum proteinase 3 and myeloperoxidase levels were determined using enzyme-linked immunosorbent assay. Results. The neutrophil infiltration of the decidual plate was 60.25 in missed abortion, 2.50 in spontaneous abortion, and 7.60 in elective abortion. Myeloperoxidase and proteinase 3 levels were significantly higher in women with miscarriage (p<0.001). Conclusion. Serum neutrophil markers may serve as potential indicators of miscarriage. A better understanding of the functional role of neutrophils in the pathophysiology of miscarriage may contribute to the development of novel prognostic tools and therapeutic strategies. Keywords: missed abortion, spontaneous miscarriage, neutrophils, netosis, placenta, decidual plate

  • Contraversations in assessment tools for missed abortion

    by T.A. Gusarova, R.R. Bayazitov, V.V. Aleksankina, M.N. Babaeva, N.V. Nizyaeva

  • Medical expulsive therapy with α1-adrenergic blockers after extracorporeal shock wave lithotripsy for urolithiasis in children.

    by I. Ashraf-Ogly Kyarimov, S.N. Zorkin, R.R. Bayazitov, A.T. Galuzinskaya, D.S. Shakhnovskiу

    Introduction. The development of medical expulsive therapy options following extracorporeal shock wave lithotripsy (ESWL) in pediatric urolithiasis plays a crucial role in accelerating stone fragment clearance. The aim: evaluation of the efficacy and safety of α1-adrenergic blockers (tamsulosin and silodosin) in pediatric patients with urinary stone disease after ESWL. Materials and Methods. We conducted a prospective comparative study of 200 patients (aged 2-18 years) divided into a study group (n=50, received α1-adrenergic blockers after ESWL) and a control group (n=150, standard therapy). Efficacy endpoints included: stone-free rate, stone fragment expulsion time, pain dynamics, analgesic requirements and α1-blocker adverse effects. Statistical analysis was performed using StatTech v.4.8.3. Results. The use of α1-adrenergic blockers increased the stone-free rate after ESWL by 1.23-fold compared to standard therapy (OR = 0.474; 95% CI: 0.229-0.980). The median stone fragment expulsion time decreased from 7 to 5 days (p=0.010). Pain intensity decreased by the second day of treatment (p<0.001), with reduced analgesic requirements (p=0.003). Adverse effects of α1-blockers were rare (5 cases of nasal congestion, 2 of nausea). Conclusion. The use of α1-blockers in children with urolithiasis after ESWL improves treatment efficacy, reduces expulsion time, and alleviates pain with a favorable safety profile.

  • Intraoperative classification to predict the development of post-resection short bowel syndrome in children

    by A.S. Gurskaya, R.R. Baiazitov, E.V. Ekimovskaya, S.N. Zorkin, E.YU. Dyakonova, I.V. Karnuta, M.A. Sulavko, F.S. Piloyan, A.S. Chernyavskaya, D.M. Akhmedova, et al.

    Post-resection short bowel syndrome (SBS) in children occurs after extensive resection of various sections of the gastrointestinal (GI) tract and manifests as chronic intestinal failure with the inability to achieve enteral autonomy. Existing classification options for SBS in children are difficult to apply in practice and do not contain information about the prognosis for the development of SBS in a particular patient. Objective. To design the intraoperative classification for predicting the development of post-resection SBS in children. Patients and methods. This study included the results of treatment of 80 children after resection of various sections of the GI tract. Based on these results, the intraoperative classification was designed to predict the development of post-resection SBS.In the group of children with extensive resections (n = 42), a statistical analysis of SBS development was performed depending on the extent and location of the resections performed, as well as the combination of resections in various sections of the GI tract in accordance with the proposed classification. Results. The classification is based on the lesion anatomical site, the extent of resection, and the presence or absence of the ileocecal angle. When comparing the development of SBS depending on the resection of the jejunum, ileum, or colon, more than 90% of patients had this disease after resection of more than 2/3 of the jejunum, and 100% of patients had SBS after resection of more than 2/3 of the colon. Conclusion. The designed intraoperative classification allows the diagnosis to be formulated in such a way that surgeons and pediatricians can understand the extent of resection performed in each individual child and predict the development of postresection SBS. Key words: intraoperative classification of short bowel syndrome, newborns, residual bowel length, extensive bowel resection, parenteral nutrition, short bowel syndrome, chronic intestinal failure, enteral autonomy

  • Open Access

    A nomogram to determine the effectiveness of remote shock wave lithotripsy in children with urolithiasis

    by Антонина Денисовна Лобанова, Сергей Николаевич Зоркин, Rimir R. Bayazitov, Dmitry S. Shakhnovskiy, Дмитрий Сергеевич Шахновский

    Introduction. The method of choice in the treatment of urolithiasis in children is remote shock wave lithotripsy (RSWL). Due to the vastness of the indications, the effectiveness of this method does not correspond to the expected one, which led to the search for predictive factors of the success of the RSWL and the creation of nomograms to determine its effectiveness. The aim of the work is to identify significant factors influencing the success of remote shock wave lithotripsy and to develop a nomogram to determine its effectiveness in children with urolithiasis. Materials and methods. Two hundred seventy nine patients (305 renal units) with renal urolithiasis were examined. The median age of the patients was 119 (44–175) months. All patients underwent a comprehensive examination. The RSWL is completed. The criterion for the effectiveness of RSWL was the absence of fragments of concretions > 3 mm in the urinary tract during a control ultrasound performed after 3 months. The data of patients between groups with successful and ineffective RSWL were compared according to the following parameters: gender, age, body mass index, presence of surgical interventions, distance from skin to stone, side of the lesion, two-sidedness of the process, exact localization of concretions, their number, size, volume, and density. Results. The parameters that have a positive effect on the outcome of RSWL are: female gender, two-sided process, location in one renal compartment, smaller size, volume and density of the stone. The effect of lithotripsy is advers affected by the age of patients from 6 to 14 years, the location of the stone in the lower group of cups. To create a nomogram, variables were selected using logistic regression analysis in accordance with the clinical and statistical significance of each of factors with a deviation of less effective signs. The final nomogram included the following variables: gender, age, exact location, multiplicity of location, and average density, size and volume of stones according to computed tomography (CT) data. Conclusion. The developed by us nomogram to determine the effectiveness of RSWL is a preoperative planning tool that allows for a personalized and objective approach to the treatment of sick children with urolithiasis. The introduction of such tools into clinical practice for evaluating the effectiveness of operations will optimize the choice of an adequate method of treating patients, increase the effectiveness of operations, reduce the number of additional surgical and anesthetic aids and the duration of the child’s stay in the hospital.


  • Open Access

    Features of the diagnostics and surgical treatment of necrotizing enterocolitis

    by Aleksandra S. Gurskaya, Ekaterina V. Ekimovskaya, Rimir R. Bayazitov, Олег Николаевич Наковкин, Сергей Николаевич Зоркин, Elena Yu. Dyakonova, Мария Александровна Сулавко, Инна Викторовна Карнута, Анна Алексеевна Клепикова, Feliks S. Piloyan, et al.

    Introduction. Necrotizing enterocolitis (NEC) is one of the common causes for abdominal surgery in newborns and infants over he first months of life with a high mortality rate (23.5%), increased in case of surgery to 67%. Materials and methods. We compared premature (n = 25) and full-term (n = 22) newborns operated for NEC complications (laparotomy, resection of necrotized sections of the intestine, intestinal stoma). Also, we evaluated the results of treatment of infants with intestinal stoma after surgical NEC (n = 110, groups 1, 2 and 3). Results. Full-term cases with congenital heart defects are at risk of surgical NEC (p < 0.05). Subtotal and total forms of NEC are associated with lethal outcomes up to 100% in both premature and full-term infants. It is necessary to preserve the ileocecal angle; length measuring of the remaining intestine along the mesenteric edge helps to predict further risks: 60 cm and less leads to 80–100% of post-resection short bowel syndrome. Conclusion. NEC in full-term newborns is due to its hypoxic nature and impaired mesenteric perfusion (congenital heart defects). Surgical NEC can occur without typical symptoms (“covered perforation”), the discrepancy between the clinical and radiographic picture may indicate to subtotal or total intestinal necrosis with up to 100% of lethal outcomes.

  • Choledochal cysts: surgical treatment in newborns and infants

    by A.B. Alkhasov, A.S. Gurskaya, R.R. Bayazitov, O.N. Nakovkin, M.A. Sulavko, I.V. Karnuta, E.V. Ekimovskaya, I.A. Kyarimov, D.M. Akhmedova, A.A. Klepikova, et al.

    OBJECTIVE To improve postoperative outcomes in newborns and infants with choledochal cysts and to determine the indications for surgery. MATERIAL AND METHODS There were 13 children aged 0—3 months with choledochal cyst who underwent reconstructive surgery between 2019 and 2023. In all children, choledochal cyst was associated with cholestasis. Acholic stool was observed in almost half of the group (n=7). All children underwent cyst resection and Roux-en-Y hepaticoenterostomy. RESULTS Symptoms of cholestasis regressed in all patients. Mean surgery time was 128±27 min. There were no complications. Enteral feeding was started after 1—2 postoperative days, abdominal drainage was removed after 6.2±1.6 days. Mean length of hospital-stay was 16±3.7 days. Adequate bile outflow is one of the main principles. For this purpose, anastomosis with intact tissues of hepatic duct should be as wide as possible. Roux-en-Y loop should be at least 40—60 cm to prevent postoperative cholangitis. CONCLUSION Drug-resistant cholestasis syndrome and complicated choledochal cysts (cyst rupture, bile peritonitis) are indications for surgical treatment in newborns and infants. When forming Roux-en-Y hepaticoenterostomy, surgeon should totally excise abnormal tissues of the biliary tract to prevent delayed malignant transformation.


  • Open Access

    Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants

    by A Gurskaya, M Sulavko, E Ekimovskaya, R Bayazitov, O Nakovkin, I Karnuta, A Klepikova, D Akhmedova, R Hagurov, G Sagoyan

    Background: Chyloperitoneum (CP) and chylothorax (CT) are rare conditions that have a high mortality rate and unclear treatment options. Their incidence in neonates ranges from 1 in 20000 to 1 in 187000 live births. This study aims to evaluate the effectiveness of synthetic somatostatin analog (octreotide) and sirolimus therapy in treating chylous pleural and peritoneal collections in newborns and infants. Methods: We conducted a retrospective analysis of 10 children with either chylothorax or chyloperitoneum, treated in our department between 2018 and 2023. The study was approved by the Local Independent Ethics Committee of The National Medical Research Center of Children's Health, under Protocol №7, dated 11 May 2023. The parents voluntarily signed an informed consent form for the off-label use of the drug. We reviewed the medical records for demographic information, clinical presentation, management, and outcome. Results: Our study looked at patients aged between 0 and 5.5 months, with seven cases of chyloperitoneum and three cases of chylothorax. We initially used octreotide, which was then switched to sirolimus if there was no improvement. Octreotide was effective in five children after 10-18 days of treatment, while the effect of sirolimus was observed 8-14 days after starting treatment. One patient, who had a history of a giant omphalocele with primary closure, experienced complications after 8 weeks of sirolimus therapy, including bilateral knee arthritis, leukopenia, and lymphopenia. Fortunately, there were no fatal outcomes. Conclusion: Sirolimus therapy is effective in treating newborns with chylothorax or chyloperitoneum, with a low risk of complications even in those cases not responding to octreotide therapy. It is recommended that octreotide therapy should not exceed 10 days, after which sirolimus can be prescribed.

  • Open Access

    Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants

    by Aleksandra Gurskaya, Mariya Sulavko, Ekaterina Ekimovskaya, Rimir Bayazitov, Oleg Nakovkin, Inna Karnuta, Anna Klepikova, Dinara Akhmedova, Ruslan Hagurov, Garik Sagoyan, et al.

    Background: Chyloperitoneum (CP) and chylothorax (CT) are rare conditions that have a high mortality rate and unclear treatment options. Their incidence in neonates ranges from 1 in 20000 to 1 in 187000 live births. This study aims to evaluate the effectiveness of synthetic somatostatin analog (octreotide) and sirolimus therapy in treating chylous pleural and peritoneal collections in newborns and infants. Methods: We conducted a retrospective analysis of 10 children with either chylothorax or chyloperitoneum, treated in our department between 2018 and 2023. The study was approved by the Local Independent Ethics Committee of The National Medical Research Center of Children's Health, under Protocol №7, dated 11 May 2023. The parents voluntarily signed an informed consent form for the off-label use of the drug. We reviewed the medical records for demographic information, clinical presentation, management, and outcome. Results: Our study looked at patients aged between 0 and 5.5 months, with seven cases of chyloperitoneum and three cases of chylothorax. We initially used octreotide, which was then switched to sirolimus if there was no improvement. Octreotide was effective in five children after 10-18 days of treatment, while the effect of sirolimus was observed 8-14 days after starting treatment. One patient, who had a history of a giant omphalocele with primary closure, experienced complications after 8 weeks of sirolimus therapy, including bilateral knee arthritis, leukopenia, and lymphopenia. Fortunately, there were no fatal outcomes. Conclusion: Sirolimus therapy is effective in treating newborns with chylothorax or chyloperitoneum, with a low risk of complications even in those cases not responding to octreotide therapy. It is recommended that octreotide therapy should not exceed 10 days, after which sirolimus can be prescribed.